Biomarkers of Nursing-Associated Functional Recovery During Extended Care

Abstract

Functional recovery remains a pivotal outcome in patients undergoing extended nursing care, particularly in post-acute, geriatric, and rehabilitation settings. In recent years, the identification and application of biomarkers have revolutionized the ability to predict, monitor, and enhance recovery trajectories. This review synthesizes current evidence on the role of biomarkers in nursing-associated functional recovery, addresses the underlying mechanisms, discusses risk stratification, and examines practical implications for clinical care, with an emphasis on emerging research and guideline-based recommendations.

Introduction

Extended care facilities increasingly serve patients with complex needs requiring not just medical stabilization but also functional rehabilitation. Understanding which patients are likely to experience favorable recovery is critical for resource allocation, individualized care planning, and optimizing long-term outcomes. Biomarkers—objective, quantifiable biological parameters—offer the potential to refine prognostication and guide interventions in nursing-associated functional recovery. This article reviews the scientific foundations, clinical significance, and future directions of biomarker integration in extended care settings.

Epidemiology / Disease Burden

Globally, the burden of functional decline and disability following acute illness, surgery, or exacerbation of chronic conditions is substantial, particularly among older adults. According to recent estimates, up to 30% of patients discharged from hospitals to extended care facilities experience incomplete or delayed functional recovery. The consequences include increased morbidity, higher rates of institutionalization, and diminished quality of life, thereby necessitating reliable tools to monitor and predict recovery trajectories. The economic impact is likewise considerable, with prolonged stays and readmissions straining healthcare systems.

Pathophysiology

Functional recovery is a complex, multifactorial process influenced by systemic inflammation, cellular senescence, neuroendocrine dysregulation, and musculoskeletal remodeling. Key pathophysiological mediators include cytokines (e.g., IL-6, TNF-α), markers of oxidative stress, and neurotrophic factors such as brain-derived neurotrophic factor (BDNF). Sarcopenia and frailty, often present in extended care populations, are underpinned by disruptions in muscle protein synthesis, mitochondrial dysfunction, and chronic low-grade inflammation. Understanding these mechanistic pathways is vital for selecting relevant biomarkers that reflect the biological underpinnings of recovery.

Risk Factors

Patient-related risk factors for poor functional recovery include advanced age, multimorbidity, pre-existing frailty, cognitive impairment, low baseline physical activity, and nutritional deficits. Procedure- and illness-related factors such as prolonged immobility, severity of acute illness, and iatrogenic complications further compromise recovery. Social determinants, including inadequate support systems and limited access to rehabilitation resources, also play significant roles. Biomarker-driven risk stratification allows for early identification of high-risk patients, enabling tailored interventions and closer monitoring during extended care.

Clinical Features

Functional recovery is typically evaluated through multidimensional assessments covering mobility, self-care, cognition, and psychosocial status. Clinically, delayed recovery manifests as persistent dependency in activities of daily living (ADLs), reduced ambulation, increased fall risk, and cognitive decline. Biomarkers add an objective layer to these assessments, supporting the detection of subclinical deterioration and facilitating more precise monitoring of response to care interventions.

Diagnosis

The diagnostic process for impaired functional recovery in extended care involves standardized functional scales (e.g., Barthel Index, Functional Independence Measure) and geriatric assessments. Biomarkers augment these tools by providing early warnings of adverse trajectories. Serum albumin, C-reactive protein (CRP), and inflammatory cytokines have all demonstrated prognostic value, while emerging molecular markers such as microRNAs and urinary proteomic signatures hold promise for further refinement.

Treatment & Management

Management strategies in extended care focus on individualized rehabilitation, optimizing comorbidity management, nutritional support, and prevention of complications such as pressure ulcers and falls. Biomarker integration can inform the intensity and type of interventions, identify candidates for advanced therapies, and monitor biological response to treatment. For instance, elevated CRP or IL-6 may prompt intensified anti-inflammatory or nutritional strategies, while low BDNF levels could support the use of cognitive and physical stimulation programs.

Recent Advances / Emerging Therapies

Recent advances in molecular diagnostics and point-of-care testing have accelerated the adoption of biomarker-driven care models. Proteomic and metabolomic profiling, as well as genomic risk scores, are under active investigation for their ability to predict recovery and response to rehabilitation. Novel biomarkers such as growth differentiation factor-15 (GDF-15), circulating microRNAs, and extracellular vesicles are being evaluated for their mechanistic relevance and clinical utility. Artificial intelligence and machine learning approaches are now leveraging multi-omic data to build predictive algorithms for functional recovery, further personalizing care.

Guideline Recommendations

Current guidelines from geriatric, rehabilitation, and nursing societies increasingly recognize the value of integrating biomarkers into the assessment and management of functional recovery. The American Geriatrics Society, for example, recommends routine assessment of nutritional and inflammatory biomarkers in high-risk populations. There is consensus that biomarker data should complement, not replace, comprehensive functional assessments and clinical judgement. Ongoing guideline development aims to standardize biomarker selection, timing, and interpretation in extended care practice.

Conclusion

The integration of biomarkers into nursing-associated functional recovery during extended care represents a paradigm shift toward more precise, individualized, and proactive patient management. By enabling early risk stratification, monitoring biological response, and informing tailored interventions, biomarkers hold the potential to transform extended care outcomes. Ongoing research and the evolution of clinical guidelines will further refine their application, helping to ensure that functional recovery is optimized for every patient in the extended care continuum.